Oritavancin for Treatment of Serious Cardiac Infections
NCT07550595
Bacterial Infections, Bacterial Infections and Mycoses
Sydney, New South Wales, Australia
View Trial DetailsNCT Number: NCT06745440
The objective of this prospective observational registry is to study patients di-agnosed with infective endocarditis (IE) and to gather comprehensive long-term outcome data, including mortality rates and IE-related complications (e.g., thromboembolic events, (hospitalization for) heart failure, valve surgery and IE recurrence) at one, three-, and five-years post-enrollment. Additionally, the registry will document epidemiological characteristics, clinical presentation at baseline, biochemical and microbiological profiles, relevant comorbidities and risk factors, diagnostic strategies, and therapeutic interventions, including an-timicrobial therapy and surgical procedures.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
> 18 yo
Time frame: 5-years
Contact information is provided by the study sponsor or research team.
Universitair Ziekenhuis Brussel
Other
Acronym: BIER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07550595
Bacterial Infections, Bacterial Infections and Mycoses
Sydney, New South Wales, Australia
View Trial DetailsNCT07029295
Cardiac Sarcoidosis, Cardiovascular Diseases
Paris, France
View Trial DetailsNCT07013552
Antibiotic Resistant Strain, Antibiotic Therapy
Katowice, Silesian Voivodeship, Poland
View Trial DetailsNCT06583902
Cardiovascular Diseases, Endocarditis
Roma, Italy
View Trial Details